BIRC5 and cancer: Survivin, a member of the inhibitor of apoptosis (IAP) family, has attracted considerable attention as an ideal target for cancer treatment since it is highly and uniquely expressed in the majority of human tumors and plays a critical role in the control of cell division and the inhibition of apoptosis (14–18).